← Back to Clinical Trials
Recruiting NCT06009263

NCT06009263 Effect of Open Chain Versus Closed Chain Segmental Control Exercises on CSA of Lumbar Multifidus Muscle in Chronic MLBP

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06009263
Status Recruiting
Phase
Sponsor Cairo University
Condition Mechanical Low Back Pain
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2023-09-02
Primary Completion 2026-06-13

Eligibility & Interventions

Sex All sexes
Min Age 25 Years
Max Age 55 Years
Study Type INTERVENTIONAL
Interventions
Conventional treatmentOpen chain segmental controlClosed chain segmental control

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2023-09-02 with a primary completion date of 2026-06-13.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

To investigate the effect of adding open versus closed chain segmental control exercises to conventional treatment program on pain intensity, lumbar ROM, and CSA of multifidus muscle.

Eligibility Criteria

Inclusion Criteria: 1. Patients with chronic low back pain from both genders their age will be ranged and divided into three groups from 25-55 years. 2. Participants with chronic low back pain lasting for more than 6 Months. 3. A patient who can follow the command. 4. A patient who can do exercise. Exclusion Criteria: 1. Low back pain patients with a history of severe neurological disease or orthopedic disease. 2. History of Psychological Disorder. 3. Unhealthy Patient. 4. Pregnant women. 5. Patient with a spinal tumor. 6. History of any operation related to spine. Ex. Vertebral fracture or dislocation.

Contact & Investigator

Central Contact

Haytham M Elhafez, PhD

✉ elhafez@yahoo.com

📞 +201001909630

Principal Investigator

Haytham M Elhafez, PhD

PRINCIPAL INVESTIGATOR

Cairo University

Frequently Asked Questions

Who can join the NCT06009263 clinical trial?

This trial is open to participants of all sexes, aged 25 Years or older, up to 55 Years, studying Mechanical Low Back Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06009263 currently recruiting?

Yes, NCT06009263 is actively recruiting participants. Contact the research team at elhafez@yahoo.com for enrollment information.

Where is the NCT06009263 trial being conducted?

This trial is being conducted at Giza, Egypt.

Who is sponsoring the NCT06009263 clinical trial?

NCT06009263 is sponsored by Cairo University. The principal investigator is Haytham M Elhafez, PhD at Cairo University. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology